Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Scientists Say They Regenerated Breasts After Cancer Surgery

This article was originally published in PharmAsia News

Executive Summary

Researchers at Japan's Tottori University say clinical trials showed success in transplanting fat mixed with a woman's stem cells to regenerate breasts after cancer surgery.

Researchers at Japan's Tottori University say clinical trials showed success in transplanting fat mixed with a woman's stem cells to regenerate breasts after cancer surgery. Five women between the ages of 30 and 60 years were reported without signs of cancer a year after their surgery and use of the transplant process. The fat was removed from the patient's abdomen or hips, mixed with her own fat stem cells and transplanted into the breast areas where tumors and surrounding tissues had been removed. No metastasiswas found a year later. (Click here for more)

"Japanese Researchers Signal Breast-Cancer Regenerative-Medicine Breakthrough" - Japan Times (3/21/2013)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC083809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel